1 | cell and gene therapies | | | | | | | 3 | 0.24% |
2 | advancement of cell and | | | | | | | 3 | 0.24% |
3 | pharmaceutical testing and approval | | | | | | | 3 | 0.24% |
4 | testing and approval of | | | | | | | 3 | 0.24% |
5 | biotech breakthrough awards program | | | | | | | 2 | 0.16% |
6 | stand out in a | | | | | | | 2 | 0.16% |
7 | the advancement of cell | | | | | | | 2 | 0.16% |
8 | use of nextgeneration computing | | | | | | | 2 | 0.16% |
9 | biotech breakthrough our mission | | | | | | | 2 | 0.16% |
10 | personalized treatment of rare | | | | | | | 2 | 0.16% |
11 | in a crowded market? | | | | | | | 2 | 0.16% |
12 | out in a crowded | | | | | | | 2 | 0.16% |
13 | validation from an independent | | | | | | | 2 | 0.16% |
14 | thirdparty validation from an | | | | | | | 2 | 0.16% |
15 | bioiconsaster pharmaceutical testing and | | | | | | | 2 | 0.16% |
16 | and thirdparty validation from | | | | | | | 2 | 0.16% |
17 | recognition and thirdparty validation | | | | | | | 2 | 0.16% |
18 | of cell and gene | | | | | | | 2 | 0.16% |
19 | bioiconsthe advancement of cell | | | | | | | 2 | 0.16% |
20 | treatment of rare diseases | | | | | | | 2 | 0.16% |
21 | work and success of | | | | | | | 1 | 0.08% |
22 | the creativity hard work | | | | | | | 1 | 0.08% |
23 | creativity hard work and | | | | | | | 1 | 0.08% |
24 | recognize the creativity hard | | | | | | | 1 | 0.08% |
25 | and recognize the creativity | | | | | | | 1 | 0.08% |
26 | hard work and success | | | | | | | 1 | 0.08% |
27 | the field of biotechnology | | | | | | | 1 | 0.08% |
28 | companies technologies and products | | | | | | | 1 | 0.08% |
29 | technologies and products within | | | | | | | 1 | 0.08% |
30 | and products within the | | | | | | | 1 | 0.08% |
31 | products within the field | | | | | | | 1 | 0.08% |
32 | within the field of | | | | | | | 1 | 0.08% |
33 | biotech breakthrough is part | | | | | | | 1 | 0.08% |
34 | breakthrough is part of | | | | | | | 1 | 0.08% |
35 | is part of the | | | | | | | 1 | 0.08% |
36 | part of the tech | | | | | | | 1 | 0.08% |
37 | of the tech breakthrough | | | | | | | 1 | 0.08% |
38 | the tech breakthrough organization | | | | | | | 1 | 0.08% |
39 | tech breakthrough organization a | | | | | | | 1 | 0.08% |
40 | leading global market intelligence | | | | | | | 1 | 0.08% |